These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 30816538)
1. Aurora kinase inhibitor VX‑680 suppresses the proliferation and migration of HUVECs and angiogenesis. Sun X; Niu S; Zhang Z; Wang A; Yang C; Guo Z; Hao Y; Li X; Wang X Mol Med Rep; 2019 May; 19(5):3841-3847. PubMed ID: 30816538 [TBL] [Abstract][Full Text] [Related]
2. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632 [TBL] [Abstract][Full Text] [Related]
3. Effects of Pien Tze Huang on angiogenesis in vivo and in vitro. Shen AL; Hong F; Liu LY; Lin JM; Zhuang QC; Hong ZF; Peng J Chin J Integr Med; 2012 Jun; 18(6):431-6. PubMed ID: 22821655 [TBL] [Abstract][Full Text] [Related]
4. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety. Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690 [TBL] [Abstract][Full Text] [Related]
6. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo. Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297 [TBL] [Abstract][Full Text] [Related]
8. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2. Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027 [TBL] [Abstract][Full Text] [Related]
9. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell. Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities. Yu G; Li Z; Tang L; Xiong Q Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275 [TBL] [Abstract][Full Text] [Related]
11. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF. Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517 [TBL] [Abstract][Full Text] [Related]
12. Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway. Ji L; Wu M; Li Z Molecules; 2018 Aug; 23(8):. PubMed ID: 30111763 [TBL] [Abstract][Full Text] [Related]
13. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cho SG; Yi Z; Pang X; Yi T; Wang Y; Luo J; Wu Z; Li D; Liu M Cancer Res; 2009 Sep; 69(17):7062-70. PubMed ID: 19671799 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis by HC·HA, a complex of hyaluronan and the heavy chain of inter-α-inhibitor, purified from human amniotic membrane. Shay E; He H; Sakurai S; Tseng SC Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2669-78. PubMed ID: 21228375 [TBL] [Abstract][Full Text] [Related]
15. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects. Gao W; Jin K; Lan H; Han N; Cao F; Teng L Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543 [